Plummer, M.Meier, J.Deane, A.2014-05-082014-05-082013Critical Care (UK), 2013; 17(4):163-1-163-21466-609X1364-8535http://hdl.handle.net/2440/82728Enteral nutrient is a potent glucagon-like peptide-1 (GLP-1) secretagogue. In vitro and animal studies indicate that GLP-1 has immune-modulatory and neuroprotective effects. To determine whether these immune-modulatory and neuroprotective effects of GLP-1 are beneficial in the critically ill, studies achieving pharmacological GLP-1 concentrations are warranted.en© 2013 BioMed Central LtdHumansEnteral NutritionImmunity, CellularIntensive Care UnitsFemaleMaleGlucagon-Like Peptide 1Journal article002013604310.1186/cc127580003315397000602-s2.0-848791197512-s2.0-8488004042215832Plummer, M. [0000-0002-9640-1911]Deane, A. [0000-0002-7620-5577]